Try our beta test site

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

This study has been completed.
Biomeasure Inc, Ipsen Group
Information provided by:
Octagen Corporation Identifier:
First received: October 25, 2005
Last updated: October 2, 2007
Last verified: October 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: No date given